(Reuters) -Haleon posted an unexpected drop in third-quarter revenue on Thursday, hurt by a weak demand for its painkiller in ...

Revenues fall at Sensodyne maker Haleon after weaker painkiller sales - Shares were lower in early trading on Thursday as a ...

Haleon’s household names such as Sensodyne and Paradontax toothpastes helped drive group revenue to £2.78bn. (Photo Illustration by Christof Koepsel/Getty Images) Consumer healthcare company ...

The body of our story starts in 2001, when GSK acquired the Sensodyne brand and identified its vast untapped potential. It concludes roughly 15 years later at the point where profit generated from the ...

This is the story of how a change in marketing strategy completely transformed the fortunes of Sensodyne. Formerly a small player in a niche category, Sensodyne is now a $1bn brand, in a category it ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

Haleon missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its ...

Haleon highlighted sharp growth in toothpaste and mouthwash brand Sensodyne, especially in India, the US, the UK and Germany, while parodontax, another toothpaste and mouthwash brand, grew double ...

(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on ...

Shares in the Sensodyne and Voltaren maker were lower in early trading on Thursday as a result. Haleon told investors that revenues declined by 0.6% to £2.78 billion for the three months to ...

Consumer healthcare company Haleon has reportedgrowth across all its categories and regions in its third quarter amid healthy ...